Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Womb (uterine or endometrial) cancer
Closed
Phase 3
This trial is comparing MK-2870 with chemotherapy for womb cancer that has come back after treatment.
It is open to women who can’t have surgery or radiotherapy to treat their womb cancer.
Recruitment start: 26 March 2024
Recruitment end: 7 May 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Shibani Nicum
Merck Sharp & Dohme LLC
Last reviewed: 08 Oct 2025
CRUK internal database number: 19862